Date:
Saturday, January 17, 2026

Time:
7:30AM - Registration / Continental Breakfast

8:30AM - Program Starts

2:00PM - Program Concludes

Venue:
Hilton Chicago/Oak Brook Conference Center, 3500 Midwest Road, Oak Brook, IL

Registration Fees: 
Physician: $75
Nurse/Nurse Practitioner/Physician Assistant: $35
Resident/Fellow: $25
Industry: $300

Regional Director
 Rita Nanda
, MD

Agenda (Times Subject To Change)

7:30 AM - 8:30 AMRegistration, Continental Breakfast, Exhibits Open 
8:30 AM - 8:45 AMWelcome and Introduction of Program and Faculty Pre-Knowledge Assessment 
8:45 AM - 9:20 AMInsights in Translational Research and Resistance MechanismsMarina Sharifi
9:20 AM - 9:55 AMApproaches to Loco-Regional DiseaseJonathan Strauss
9:55 AM - 10:25 AMAdvances of HER2+ DiseaseAdrienne Waks
10:25 AM - 10:40 AMRefreshment Break with Exhibitors 
10:40 AM - 11:15 AMAdvances of HR+ Breast CancerCynthia Ma, MD, PhD
11:15 AM - 12:15 PMLunch Break - Exhibits Open 
11:30 AM - 12:15 PMSupported Symposium - Offering an ADC Treatment for Patients With Pretreated HR+/HER2- mBC and mTNBCShaina Rozell, MD
12:15 PM - 12:50 PMUpdates in TNBCRita Nanda
12:50 PM - 1:25 PMNew Directions in Breast Cancer Prevention and Approaches to Risk ReductionMaryam Lustberg
1:45 PM - 2:00 PMWrap-up and Post Test 
2:00 PMAdjournment 

Program Overview

Breast cancer research continues to advance scientific and clinical knowledge of the disease and bring new techniques, treatments, and strategies to practicing clinicians. As such, clinicians need to stay current with best practices and clinical updates in prevention, screening, diagnosis, and treatment of breast cancer. Understanding results from recent clinical trials and key topics in breast cancer will help clinicians optimize management of patients with breast cancer and ultimately improve patient outcomes.

Learning Objectives

After participating in the Best of SABCS®️ program, learners will be able to:

1.⁠ ⁠INTERPRET recent advancements and research in breast cancer diagnosis, treatment, and specific considerations to enhance the care and outcomes of a diverse community of cancer patients.


2.⁠ ⁠LEVERAGE recent developments in the assessment and management of breast cancer subtypes to identify the most appropriate treatment strategies for people with breast cancer.


3.⁠ ⁠CONSTRUCT risk-adapted management strategies to optimize patient satisfaction, adherence, and treatment efficacy.


4.⁠ ⁠INTEGRATE new evidence from clinical trials in all aspects of breast cancer care presented during poster presentations and educational sessions at the annual San Antonio Breast Cancer Symposium into clinical practice in order to improve patient care.

Target Audience

This official Best of SABCS program is directed to practicing oncologists (medical, surgical, radiation), community physicians, medical residents and fellows training in oncology, as well as other pertinent healthcare professionals involved in oncology medicine.

This Program is Supported with Educational Grants from
AstraZeneca, Daiichi Sankyo, Exact Sciences, Genentech, Lilly, Novartis, and Stemline/ Menarini

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint-providership of the University of Texas at San Antonio and Encore Medical Education, LLC.

The University of Texas at San Antonio is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Texas at San Antonio designates this live activity up to a maximum of 3.75 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation.

Interested in Exhibiting?
www.bestofsabcs.com/sponsorship